Pulmonary Fibrosis Treatment Guidelines
Pulmonary fibrosis treatment guidelines have been developed to diagnose and treat the symptoms of this progressive lung disease. Pulmonary fibrosis is most commonly treated using either medication, which helps to decrease inflammation, or oxygen therapy, which helps to increase the levels of oxygen in the blood. For some people living with pulmonary fibrosis, these treatments can effectively minimize their symptoms. Traditional treatment often has unwanted side effects, however, and does not work for everyone.
At the Lung Institute, our approach to treating pulmonary fibrosis includes a natural alternative to traditional methods: cellular therapy. Using regenerative medicine to treat lung disease has the potential to slow the progression of pulmonary fibrosis and improve the overall function of the lungs, all while helping to manage the symptoms associated with the condition.
We offer two different forms of cellular therapy at the Lung Institute:
- Venous cellular therapy, in which the cells are derived from the patient’s blood
- Bone marrow cellular therapy, in which the cells are taken from a small amount of the patient’s bone marrow
Both of these procedures are performed by experienced professionals who utilize minimally invasive techniques, and both types of treatment are administered on an outpatient basis over the course of two days. And because our cellular therapys use autologous cells, or cells derived from the patient’s own body, they have minimal risk of side effects and the risk of rejection is virtually nonexistent.
To learn more about pulmonary fibrosis treatment guidelines as it relates to cellular therapy available at the Lung Institute, call our team today at (800) 729-3065.